Member access

4-Traders Homepage  >  Shares  >  SHANGHAI STOCK EXCHANGE  >  Jiangzhong Pharmaceutical Co Ltd    600750   CNE000000M80

End-of-day quote. End-of-day quote SHANGHAI STOCK EXCHANGE - 01/23
22.68 CNY   -0.79%
 SummaryQuotesChart AnalysisAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
01/19/2015 01/20/2015 01/21/2015 01/22/2015 01/23/2015 Date
20.83(c) 21.89(c) 22.23(c) 22.86(c) 22.68(c) Last
6 836 216 9 132 840 9 393 858 9 563 807 5 102 308 Volume
-0.90% +5.09% +1.55% +2.83% -0.79% Change
More quotes
Company
Jiangzhong Pharmaceutical Co. Ltd. is engaged in the manufacture and sale of pharmaceutical products.Main products consist of Chinese, water-soluble and botanical medicines; penicillin injection and raw materials; capsules; antibiotics and others.Other activities include wholesale and retail of... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Jiangzhong Pharmaceutical
Trading Rating : Investor Rating :
More Ratings
Chart JIANGZHONG PHARMACEUTICAL
Duration : Period :
Jiangzhong Pharmaceutical  Technical Analysis Chart | 600750 | CNE000000M80 | 4-Traders
Full-screen chart
Financials ( CNY)
Sales 2014 3 444 M
EBIT 2014 246 M
Net income 2014 210 M
Finance 2014 374 M
Yield 2014 1,41%
Sales 2015 3 518 M
EBIT 2015 311 M
Net income 2015 267 M
Finance 2015 458 M
Yield 2015 1,61%
PER 2014 32,73
PER 2015 25,82
EV / Sales 2014 1,87x
EV / Sales 2015 1,80x
Capitalization 6 807 M
More Financials
Latest news on JIANGZHONG PHARMACEUTICAL

- No features available -

More news
Sector news Pharmaceuticals - NEC
03:32p PFIZER : Report of Pfizer acquisition approach boosts Teva
09:03aDJMARKET SNAPSHOT : Apple Earnings, Fed Vie For Investor Attention This Week
01/24DJNPS PHARMACEUTICALS : Correction to NPS Hormone Drug Article on Friday
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF